1,3,5-Triazines: A promising scaffold for anticancer drugs development

Eur J Med Chem. 2017 Dec 15:142:523-549. doi: 10.1016/j.ejmech.2017.09.035. Epub 2017 Oct 6.

Abstract

This review covering literature reports from the beginning of this century to 2016 describes the synthetic pathways, the antitumor activity, the structure-activity relationship and, whenever reported, the possible mechanism of action of 1,3,5-triazine derivatives as well as of their hetero-fused compounds. Many 1,3,5-triazine derivatives, both uncondensed and hetero-fused, have shown remarkable antitumor activities and some of them reached clinical development.

Keywords: 1,3,5-Triazines; Antitumor activity; Disubstituted 1,3,5-triazines; Heterofused 1,3,5-triazines; Nitrogen heterocycles; Trisubstituted 1,3,5-triazines.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Chemistry Techniques, Synthetic / methods
  • Drug Discovery* / methods
  • Humans
  • Models, Molecular
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Structure-Activity Relationship
  • Triazines / chemical synthesis
  • Triazines / chemistry*
  • Triazines / pharmacology*

Substances

  • Antineoplastic Agents
  • Triazines